Response to first-line chemotherapy regimen to predict efficacy of nivolumab in lung cancer.
| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | Response to first-line chemotherapy regimen to predict efficacy of nivolumab in lung cancer. |
| Type de publication | Journal Article |
| Year of Publication | 2017 |
| Auteurs | Kaderbhai CGuillaume, Richard C, Fumet JDavid, Aarnink A, Ortiz-Cuaran S, Perol M, Faucher P, Coudert BP, Favier L, Lagrange A, Limagne E, Hofman P, Saintigny P, Ghiringhelli F |
| Journal | JOURNAL OF CLINICAL ONCOLOGY |
| Volume | 35 |
| Date Published | MAY 20 |
| Type of Article | Meeting Abstract |
| ISSN | 0732-183X |
| DOI | 10.1200/JCO.2017.35.15_suppl.3026 |